Journal Information
Vol. 99. Issue 4.
Pages 257-261 (May 2008)
Share
Share
Download PDF
More article options
Vol. 99. Issue 4.
Pages 257-261 (May 2008)
Practical dermatology
Full text access
Management of Androgenetic Alopecia in Postmenopausal Women
Manejo de la Alopecia Androgenética en Mujeres Posmenopáusicas
Visits
7293
R. Rivera, A. Guerra-Tapia
Corresponding author
aguerra.hdoc@salud.madrid.org

Correspondence: Servicio de Dermatología, Hospital Universitario 12 de Octubre, Avda. de Córdoba s/n, 28041 Madrid, Spain.
Servicio de Dermatología, Hospital Universitario 12 de Octubre, Madrid, Spain
This item has received
Article information
Abstract

Female androgenetic alopecia or female-pattern alopecia is one of the most common causes of hair loss, affecting 50% of women over their lifetime. The appearance of this condition is the cause of significant stress and psychological problems, making appropriate management important. Cases exist in which it is associated with hyperandrogenism. Here, we review the different clinical forms (diffuse, male-pattern, and Christmas-tree pattern), discuss the most appropriate laboratory tests (complete blood count, thyroid stimulating hormone, ferritin, prolactin, free and/or total testosterone, and dehydroepiandrosterone sulfate), and the different treatments, including finasteride.

Key words:
female androgenetic alopecia
female-pattern alopecia
finasteride
Resumen

La alopecia androgenética femenina, o alopecia de patrón femenino, es una de las causas más frecuentes de caída de pelo, afectando al 50% de las féminas a lo largo de su vida. Su aparición origina importante estrés y problemas psicológicos, de ahí la relevancia de un manejo adecuado. Hay casos que se asocian a hiperandrogenismo. En este trabajo revisamos las distintas formas clínicas –difusa, similar a la masculina y en árbol de Navidad–, discutimos las pruebas de laboratorio más indicadas (hemograma, tirotropina [TSH], ferritina, prolactina, testoterona libre y/o total y dehidroepiandrosterona sulfato) y los distintos tratamientos, entre ellos la finasterida.

Palabras clave:
alopecia androgenética femenina
alopecia de patrón femenino
finasterida
Full text is only aviable in PDF
References
[1.]
T.F. Cash, V.H. Price, R.C. Savin.
Psychological effects of androgenetic alopecia on women: Comparisons with balding men and with female control subjects.
J Am Acad Dermatol, 29 (1993), pp. 568-575
[2.]
F. Camacho.
Aspectos psicológicos de la alopecia androgenética.
Monogr Dermatol, 11 (1998), pp. 335-342
[3.]
F. Camacho, M.J. García-Hernández.
Psychological features of androgenetic alopecia.
J Eur Acad Dermatol Venereol, 16 (2002), pp. 467-480
[4.]
V.H. Price.
Androgenetic alopecia in women.
J Investig Dermatol Symp Proc, 8 (2003), pp. 24-27
[5.]
M.P. Birch, J.F. Messenger, A.G. Messenger.
Hair density, hair diameter and the prevalence of female pattern hair loss.
Br J Dermatol, 144 (2001), pp. 297-304
[6.]
M. Courtois, G. Loussouarn, C. Hourseau, J.F. Grollier.
Ageing and hair cycles.
Br J Dermatol, 132 (1995), pp. 86-93
[7.]
E. Ludwig.
Classification of the types of androgenetic alopecia (common baldness) occurring in female sex.
Br J Dermatol, 97 (1977), pp. 247-254
[8.]
J.B. Hamilton.
Patterned loss of hair in man: types and incidence.
Ann N Y Acad Sci, 53 (1951), pp. 708-728
[9.]
V.A. Venning, R.P. Dawber.
Patterned alopecia in women.
J Am Acad Dermatol, 18 (1988), pp. 1073-1077
[10.]
E.A. Olsen.
The midline part: an important physical clue to the clinical diagnosis of androgenetic alopecia in women.
J Am Acad Dermatol, 40 (1999), pp. 106-109
[11.]
E.A. Olsen.
Female pattern hair loss.
J Am Acad Dermatol, 45 (2001), pp. S70-S80
[12.]
W. Futterweit, A. Dunaif, H.-C. Yeh, P. Kingsley.
The prevalence of hyperandrogenism in 109 consecutive female patients with diffuse alopecia.
J Am Acad Dermatol, 19 (1988), pp. 831-836
[13.]
I.J. Frieden, V.H. Price.
Androgenetic alopecia.
Pathogenesis of skin disease, pp. 41-55
[14.]
M.E. Sawaya, V.H. Price.
Different levels of 5-reductase type I and II, aromatase and androgen receptor in hair follicles of women and men with androgenetic alopecia.
J Invest Dermatol, 109 (1997), pp. 296-300
[15.]
E.A. Olsen, A.G. Messenger, J. Shapiro, W.F. Bergfeld, M.K. Hordinsky, J.L. Roberts, et al.
Evaluation and treatment of male and female pattern hair loss.
J Am Acad Dermatol, 52 (2005), pp. 301-311
[16.]
V.H. Price, J.L. Roberts, M. Hordinsky, E.A. Olsen, R. Savin, W. Bergfeld, et al.
Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia.
J Am Acad Dermatol, 43 (2000), pp. 768-776
[17.]
K.W. Shum, D.R. Cullen, A.G. Messenger.
Hair loss in women with hyperandrogenism: four cases responding to finasteride.
J Am Acad Dermatol, 47 (2002), pp. 733-739
[18.]
K.E. Thai, R.D. Sinclair.
Finasteride for female androgenetic alopecia.
Br J Dermatol, 147 (2002), pp. 812-813
[19.]
R.M. Trüeb, Swiss Trichology Study Group.
Finasteride treatment of patterned hair loss in normoandrogenic postmenopausal women.
Dermatology, 209 (2004), pp. 202-207
[20.]
M. Iorizzo, C. Vincenzi, S. Voudouris, B.M. Piraccini, A. Tosti.
Finasteride treatment of female pattern hair loss.
Arch Dermatol, 142 (2006), pp. 298-302
[21.]
F. Camacho.
Hirsutismo. Enfoque clínico-terapéutico (2.ª parte).
Act Terap Dermatol, 24 (2001), pp. 190-206
[22.]
F. Camacho, A. Tosti.
Tratamiento médico de las alopecias femeninas.
Monogr Dermatol, 18 (2005), pp. 92-117
[23.]
R. Rivera, A. Guerra-Tapia.
¿Sirve la finasterida en la alopecia de la mujer?.
Mas Dermatol, 1 (2007), pp. 21-24
Copyright © 2008. Academia Española de Dermatología y Venereología and Elsevier España, S.L.
Idiomas
Actas Dermo-Sifiliográficas
Article options
Tools
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?